$MRKR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Marker Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Marker Therapeutics, Inc.. Get notifications about new insider transactions in Marker Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | MRKR | Marker Therapeutic ... | ELMS STEVE | Director | Grant | A | 0.00 | 12,658 | 0 | 29,680 | 17 K to 29.7 K (+74.36 %) |
Jun 10 2021 | MRKR | Marker Therapeutic ... | Eansor Norman David | Director | Grant | A | 0.00 | 12,658 | 0 | 36,940 | 24.3 K to 36.9 K (+52.13 %) |
Jun 10 2021 | MRKR | Marker Therapeutic ... | Wilson John Robert | Director | Grant | A | 0.00 | 12,658 | 0 | 7,812,008 | 7.8 M to 7.8 M (+0.16 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Walker Paul Edward | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Sonsini Peter W. | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Chang Carmen | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Behbahani Ali | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | BASKETT FOREST | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 1.75 | 5,714,285 | 9,999,999 | 10,714,285 | 5 M to 10.7 M (+114.29 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Wilson John Robert | Director | Buy | P | 1.75 | 1,714,285 | 2,999,999 | 7,799,350 | 6.1 M to 7.8 M (+28.17 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Buy | P | 1.75 | 571,428 | 999,999 | 2,564,487 | 2 M to 2.6 M (+28.67 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Buy | P | 1.75 | 142,857 | 250,000 | 332,568 | 189.7 K to 332.6 K (+75.30 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | ELMS STEVE | Director | Buy | P | 1.75 | 1,142,857 | 2,000,000 | 3,142,857 | 2 M to 3.1 M (+57.14 %) |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 3.29 | 140,000 | 460,600 | 140,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 3.29 | 40,000 | 131,600 | 40,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 3.29 | 140,000 | 460,600 | 140,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Koneru Mythili | Chief Medical Offic ... | Option Exercise | A | 3.29 | 140,000 | 460,600 | 140,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Kim Anthony H. | Chief Financial Off ... | Option Exercise | A | 3.29 | 160,000 | 526,400 | 160,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Hoang Tsvetelina P | VP, Research and De ... | Option Exercise | A | 3.29 | 40,000 | 131,600 | 40,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 3.06 | 430,000 | 1,315,800 | 430,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Garrett Gerald | Vice President, Cli ... | Option Exercise | A | 3.29 | 40,000 | 131,600 | 40,000 | |
Feb 12 2021 | MRKR | Marker Therapeutic ... | Agopyan Nadia | VP, Regulatory Affa ... | Option Exercise | A | 3.29 | 40,000 | 131,600 | 40,000 | |
Jun 19 2020 | MRKR | Marker Therapeutic ... | Eastern Capital LTD | 10% Owner | Option Exercise | J | 15.00 | 416,667 | 6,250,005 | 0 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 388,800 | 824,256 | 388,800 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 41,200 | 87,344 | 41,200 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 388,800 | 824,256 | 388,800 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Option Exercise | A | 2.12 | 41,200 | 87,344 | 41,200 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 113,400 | 240,408 | 113,400 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 26,600 | 56,392 | 26,600 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 32,500 | 68,900 | 32,500 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 7,500 | 15,900 | 7,500 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 113,400 | 240,408 | 113,400 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Vera Juan | Chief Development O ... | Option Exercise | A | 2.12 | 26,600 | 56,392 | 26,600 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 32,500 | 68,900 | 32,500 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Szymanska Anna | Vice President, Qua ... | Option Exercise | A | 2.12 | 7,500 | 15,900 | 7,500 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 119,100 | 252,492 | 119,100 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 20,900 | 44,308 | 20,900 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 119,100 | 252,492 | 119,100 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Loiacono Michael | Chief Accounting Of ... | Option Exercise | A | 2.12 | 20,900 | 44,308 | 20,900 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Koneru Mythili | Chief Medical Offic ... | Option Exercise | A | 2.12 | 116,100 | 246,132 | 116,100 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Koneru Mythili | Chief Medical Offic ... | Option Exercise | A | 2.12 | 23,900 | 50,668 | 23,900 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Kim Anthony H. | Chief Financial Off ... | Option Exercise | A | 2.12 | 127,500 | 270,300 | 127,500 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Kim Anthony H. | Chief Financial Off ... | Option Exercise | A | 2.12 | 32,500 | 68,900 | 32,500 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Tsvetelina P | VP, Research and De ... | Option Exercise | A | 2.12 | 25,400 | 53,848 | 25,400 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Hoang Tsvetelina P | VP, Research and De ... | Option Exercise | A | 2.12 | 14,600 | 30,952 | 14,600 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Garrett Gerald | Vice President, Cli ... | Option Exercise | A | 2.12 | 38,300 | 81,196 | 38,300 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Garrett Gerald | Vice President, Cli ... | Option Exercise | A | 2.12 | 1,700 | 3,604 | 1,700 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Agopyan Nadia | VP, Regulatory Affa ... | Option Exercise | A | 2.12 | 32,700 | 69,324 | 32,700 | |
Mar 12 2020 | MRKR | Marker Therapeutic ... | Agopyan Nadia | VP, Regulatory Affa ... | Option Exercise | A | 2.12 | 7,300 | 15,476 | 7,300 | |
Feb 20 2020 | MRKR | Marker Therapeutic ... | Eastern Capital LTD | 10% Owner | Option Exercise | X | 1.20 | 416,667 | 500,000 | 0 | |
Feb 20 2020 | MRKR | Marker Therapeutic ... | Eastern Capital LTD | 10% Owner | Buy | X | 1.20 | 416,667 | 500,000 | 4,050,001 | 3.6 M to 4.1 M (+11.47 %) |
Aug 19 2019 | MRKR | Marker Therapeutic ... | Agopyan Nadia | VP, Regulatory Affa ... | Option Exercise | A | 4.80 | 200,000 | 960,000 | 200,000 | |
Aug 15 2019 | MRKR | Marker Therapeutic ... | Hoang Peter L. | President and CEO | Buy | P | 4.62 | 10,000 | 46,200 | 189,711 | 179.7 K to 189.7 K (+5.56 %) |
Aug 08 2019 | MRKR | Marker Therapeutic ... | ELMS STEVE | Director | Option Exercise | A | 4.21 | 12,500 | 52,625 | 12,500 | |
May 13 2019 | MRKR | Marker Therapeutic ... | Eansor Norman David | Director | Grant | A | 0.00 | 7,260 | 0 | 7,260 | 0 to 7.3 K |
May 13 2019 | MRKR | Marker Therapeutic ... | Wilson John Robert | Director | Grant | A | 0.00 | 7,260 | 0 | 6,068,043 | 6.1 M to 6.1 M (+0.12 %) |
May 13 2019 | MRKR | Marker Therapeutic ... | Laskow-Pooley David | Director | Grant | A | 0.00 | 7,260 | 0 | 25,543 | 18.3 K to 25.5 K (+39.71 %) |
May 13 2019 | MRKR | Marker Therapeutic ... | Wasserman Frederick Gerald | Director | Grant | A | 0.00 | 7,260 | 0 | 25,543 | 18.3 K to 25.5 K (+39.71 %) |
Nov 29 2018 | TPIV | Marker Therapeutic ... | Kim Anthony H. | Chief Financial Off ... | Option Exercise | A | 6.81 | 400,000 | 2,724,000 | 400,000 | |
Oct 23 2018 | TPIV | Marker Therapeutic ... | Hoang Peter L. | Chief Executive Off ... | Option Exercise | A | 9.18 | 200,000 | 1,836,000 | 200,000 | |
Oct 23 2018 | TPIV | Marker Therapeutic ... | Hoang Peter L. | Chief Executive Off ... | Option Exercise | A | 9.18 | 1,359,855 | 12,483,469 | 1,359,855 | |
Oct 23 2018 | TPIV | Marker Therapeutic ... | Vera Juan | Director | Option Exercise | A | 9.18 | 500,000 | 4,590,000 | 500,000 | |
Oct 23 2018 | TPIV | Marker Therapeutic ... | Loiacono Michael | Chief Financial Off ... | Option Exercise | A | 9.18 | 300,000 | 2,754,000 | 300,000 | |
Oct 19 2018 | TPIV | Marker Therapeutic ... | Eansor Norman David | Director | Option Exercise | A | 8.34 | 12,500 | 104,250 | 12,500 | |
Oct 19 2018 | TPIV | Marker Therapeutic ... | Wilson John Robert | Director | Option Exercise | A | 8.34 | 12,500 | 104,250 | 12,500 | |
Oct 17 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Grant | A | 0.00 | 4,106 | 0 | 17,221 | 13.1 K to 17.2 K (+31.31 %) |
Oct 17 2018 | TPIV | TAPIMMUNE INC. | Grisewood Sherry | Director | Grant | A | 0.00 | 4,106 | 0 | 19,582 | 15.5 K to 19.6 K (+26.53 %) |
Oct 17 2018 | TPIV | TAPIMMUNE INC. | Reddish Mark | Director | Grant | A | 0.00 | 4,106 | 0 | 36,110 | 32 K to 36.1 K (+12.83 %) |
Oct 17 2018 | TPIV | TAPIMMUNE INC. | Laskow-Pooley David | Director | Grant | A | 0.00 | 5,168 | 0 | 18,283 | 13.1 K to 18.3 K (+39.41 %) |
Oct 17 2018 | TPIV | TAPIMMUNE INC. | Wasserman Frederick Gerald | Director | Grant | A | 0.00 | 5,168 | 0 | 18,283 | 13.1 K to 18.3 K (+39.41 %) |
Oct 10 2018 | TPIV | TAPIMMUNE INC. | WILSON GLYNN | Director | Option Exercise | M | 0.00 | 31,120 | 0 | 0 | |
Oct 10 2018 | TPIV | TAPIMMUNE INC. | WILSON GLYNN | Director | Payment of Exercise | F | 0.00 | 7,561 | 0 | 181,776 | 189.3 K to 181.8 K (-3.99 %) |
Oct 10 2018 | TPIV | TAPIMMUNE INC. | WILSON GLYNN | Director | Grant | A | 0.00 | 31,120 | 0 | 189,337 | 158.2 K to 189.3 K (+19.67 %) |
Sep 25 2018 | TPIV | TAPIMMUNE INC. | WILSON GLYNN | Director | Option Exercise | A | 0.00 | 31,120 | 0 | 31,120 | |
May 16 2018 | TPIV | TAPIMMUNE INC. | Eastern Capital LTD | 10% Owner | Buy | P | 2.40 | 1,300,000 | 3,120,000 | 5,300,002 | 4 M to 5.3 M (+32.50 %) |
Mar 02 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Option Exercise | J | 7.20 | 49,167 | 354,002 | 49,167 | |
Mar 02 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Option Exercise | J | 15.00 | 31,093 | 466,395 | 31,093 | |
Mar 02 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Option Exercise | J | 4.50 | 10,574 | 47,583 | 10,574 | |
Mar 02 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Option Exercise | J | 9.00 | 41,667 | 375,003 | 41,667 | |
Mar 02 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Option Exercise | J | 6.00 | 44,000 | 264,000 | 44,000 | |
Mar 02 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Option Exercise | J | 1.20 | 41,667 | 50,000 | 41,667 | |
Mar 02 2018 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Buy | J | 0.00 | 153,333 | 0 | 153,333 | 0 to 153.3 K |
Sep 26 2017 | TPIV | TAPIMMUNE INC. | WILSON GLYNN | Director | Payment of Exercise | F | 3.18 | 27,350 | 86,973 | 158,217 | 185.6 K to 158.2 K (-14.74 %) |
Sep 26 2017 | TPIV | TAPIMMUNE INC. | WILSON GLYNN | Director | Grant | A | 3.18 | 100,000 | 318,000 | 185,567 | 85.6 K to 185.6 K (+116.87 %) |
Sep 25 2017 | TPIV | TAPIMMUNE INC. | Hoang Peter L. | CEO and President | Payment of Exercise | F | 3.18 | 70,289 | 223,519 | 179,711 | 250 K to 179.7 K (-28.12 %) |
Sep 25 2017 | TPIV | TAPIMMUNE INC. | Hoang Peter L. | CEO and President | Grant | A | 3.18 | 250,000 | 795,000 | 250,000 | 0 to 250 K |
Aug 30 2017 | TPIV | TAPIMMUNE INC. | Silverman Joshua | Director | Grant | A | 0.00 | 13,115 | 0 | 13,115 | 0 to 13.1 K |
Aug 30 2017 | TPIV | TAPIMMUNE INC. | Wasserman Frederick Gerald | Director | Grant | A | 0.00 | 13,115 | 0 | 13,115 | 0 to 13.1 K |
Aug 30 2017 | TPIV | TAPIMMUNE INC. | Laskow-Pooley David | Director | Grant | A | 0.00 | 13,115 | 0 | 13,115 | 0 to 13.1 K |
Aug 30 2017 | TPIV | TAPIMMUNE INC. | Grisewood Sherry | Director | Grant | A | 0.00 | 13,115 | 0 | 15,476 | 2.4 K to 15.5 K (+555.48 %) |
Aug 30 2017 | TPIV | TAPIMMUNE INC. | Reddish Mark | Director | Grant | A | 0.00 | 13,115 | 0 | 32,004 | 18.9 K to 32 K (+69.43 %) |
Mar 13 2017 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Chief Executive Off ... | Grant | A | 0.00 | 12,761 | 0 | 85,567 | 72.8 K to 85.6 K (+17.53 %) |
Mar 13 2017 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | President and COO | Grant | A | 0.00 | 5,220 | 0 | 26,054 | 20.8 K to 26.1 K (+25.06 %) |
Dec 14 2016 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | President and COO | Option Exercise | M | 1.74 | 10,417 | 18,126 | 85,416 | |
Dec 14 2016 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | President and COO | Gift | G | 0.00 | 10,417 | 0 | 10,417 | 0 to 10.4 K |
Dec 14 2016 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | President and COO | Gift | G | 0.00 | 10,417 | 0 | 20,834 | 31.3 K to 20.8 K (-33.33 %) |
Dec 14 2016 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | President and COO | Buy | M | 1.74 | 10,417 | 18,126 | 31,251 | 20.8 K to 31.3 K (+50.00 %) |
Nov 30 2016 | TPIV | TAPIMMUNE INC | Silverman Joshua | Director | Option Exercise | A | 4.82 | 12,500 | 60,250 | 12,500 | |
Aug 25 2016 | TPIV | TAPIMMUNE INC | Loiacono Michael | Chief Financial Off ... | Option Exercise | A | 0.48 | 650,000 | 308,750 | 650,000 | |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 0.60 | 5,000,000 | 3,000,000 | 1 | |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 0.60 | 5,000,000 | 3,000,000 | 1 | |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | X | 0.50 | 5,000,000 | 2,500,000 | 0 | |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | X | 0.50 | 5,000,000 | 2,500,000 | 0 | |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Buy | J | 0.00 | 3,000,000 | 0 | 28,000,000 | 25 M to 28 M (+12.00 %) |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Buy | J | 0.00 | 3,000,000 | 0 | 28,000,000 | 25 M to 28 M (+12.00 %) |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Buy | X | 0.50 | 5,000,000 | 2,500,000 | 25,000,000 | 20 M to 25 M (+25.00 %) |
Aug 12 2016 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Buy | X | 0.50 | 5,000,000 | 2,500,000 | 25,000,000 | 20 M to 25 M (+25.00 %) |
Jul 19 2016 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | See Remarks | Option Exercise | A | 0.48 | 750,000 | 356,250 | 1,150,000 | |
Jul 19 2016 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | See Remarks | Grant | A | 0.00 | 250,000 | 0 | 250,000 | 0 to 250 K |
Jan 28 2016 | TPIV | TAPIMMUNE INC | Wasserman Frederick Gerald | Director | Option Exercise | A | 0.63 | 150,000 | 94,500 | 150,000 | |
Nov 16 2015 | TPIV | TAPIMMUNE INC | Reddish Mark | Director | Option Exercise | A | 0.61 | 150,000 | 90,750 | 154,500 | |
Nov 16 2015 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Director | Option Exercise | A | 0.61 | 2,000,000 | 1,210,000 | 2,038,000 | |
Nov 16 2015 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Director | Payment of Exercise | F | 0.61 | 86,782 | 52,503 | 873,675 | 786.9 K to 873.7 K (+11.03 %) |
Nov 16 2015 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Director | Grant | A | 0.61 | 315,000 | 190,575 | 960,457 | 645.5 K to 960.5 K (+48.80 %) |
Nov 16 2015 | TPIV | TAPIMMUNE INC | Grisewood Sherry | Director | Option Exercise | A | 0.61 | 150,000 | 90,750 | 150,000 | |
Nov 13 2015 | TPIV | TAPIMMUNE INC | Grisewood Sherry | Director | Buy | J | 0.80 | 28,125 | 22,500 | 28,330 | 205 to 28.3 K (+13,719.51 %) |
Nov 13 2015 | TPIV | TAPIMMUNE INC | Reddish Mark | Director | Option Exercise | A | 17.00 | 2,500 | 42,500 | 4,500 | |
Nov 13 2015 | TPIV | TAPIMMUNE INC | Reddish Mark | Director | Option Exercise | A | 17.00 | 2,000 | 34,000 | 2,000 | |
Nov 13 2015 | TPIV | TAPIMMUNE INC | Reddish Mark | Director | Buy | J | 0.80 | 225,000 | 180,000 | 226,667 | 1.7 K to 226.7 K (+13,497.30 %) |
Nov 13 2015 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Director | Option Exercise | A | 17.00 | 1,600 | 27,200 | 38,000 | |
Nov 13 2015 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Director | Grant | A | 1.00 | 120,000 | 120,000 | 645,457 | 525.5 K to 645.5 K (+22.84 %) |
Nov 13 2015 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Director | Buy | J | 0.80 | 513,319 | 410,655 | 525,457 | 12.1 K to 525.5 K (+4,229.02 %) |
Nov 13 2015 | TPIV | TAPIMMUNE INC | Laskow-Pooley David | Director | Option Exercise | A | 0.21 | 150,000 | 31,500 | 150,000 | |
Nov 09 2015 | TPIV | TAPIMMUNE INC | BONFIGLIO JOHN N | Director | Option Exercise | A | 0.57 | 150,000 | 85,500 | 400,000 | |
Sep 11 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | X | 0.20 | 10,000,000 | 2,000,000 | 0 | |
Sep 11 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Buy | X | 0.20 | 10,000,000 | 2,000,000 | 20,000,000 | 10 M to 20 M (+100.00 %) |
Jun 18 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | X | 0.50 | 5,000,000 | 2,500,000 | 1 | |
Jun 18 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Buy | X | 0.50 | 5,000,000 | 2,500,000 | 10,000,000 | 5 M to 10 M (+100.00 %) |
Jun 01 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 0.50 | 10,000,000 | 5,000,000 | 1 | |
Jun 01 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 1.00 | 5,000,000 | 5,000,000 | 0 | |
Jun 01 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 0.20 | 10,000,000 | 2,000,000 | 1 | |
Jun 01 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 0.40 | 5,000,000 | 2,000,000 | 0 | |
Jun 01 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 0.10 | 5,000,000 | 500,000 | 1 | |
Jun 01 2015 | TPIV | TAPIMMUNE INC | Eastern Capital LTD | 10% Owner | Option Exercise | J | 1.50 | 5,000,000 | 7,500,000 | 0 | |
Apr 24 2012 | TPIV | TAPIMMUNE INC | WILSON GLYNN | CEO | Buy | J | 0.15 | 166,667 | 25,000 | 1,213,726 | 1 M to 1.2 M (+15.92 %) |
Apr 20 2012 | TPIV | TAPIMMUNE INC | CORIN DENIS | President | Buy | J | 0.15 | 166,667 | 25,000 | 2,394,535 | 2.2 M to 2.4 M (+7.48 %) |
Apr 05 2011 | TPIV | TAPIMMUNE INC | CORIN DENIS | President and CFO | Sell | S | 0.12 | 160,000 | 19,200 | 135,300 | 295.3 K to 135.3 K (-54.18 %) |
Apr 05 2011 | TPIV | TAPIMMUNE INC | CORIN DENIS | President and CFO | Buy | J | 0.17 | 294,118 | 50,000 | 2,227,868 | 1.9 M to 2.2 M (+15.21 %) |
Apr 05 2011 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Chairman and CEO | Buy | J | 0.17 | 147,059 | 25,000 | 1,047,059 | 900 K to 1 M (+16.34 %) |
Oct 26 2009 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Executive Chairman | Option Exercise | A | 0.97 | 1,600,000 | 1,552,000 | 1,640,000 | |
Oct 26 2009 | TPIV | TAPIMMUNE INC | WILSON GLYNN | Executive Chairman | Buy | J | 0.10 | 900,000 | 90,000 | 900,000 | 0 to 900 K |
Oct 26 2009 | TPIV | TAPIMMUNE INC | CORIN DENIS | President | Option Exercise | A | 0.97 | 1,100,000 | 1,067,000 | 1,180,000 | |
Oct 26 2009 | TPIV | TAPIMMUNE INC | CORIN DENIS | President | Option Exercise | A | 2.00 | 14,458 | 28,916 | 54,458 | |
Oct 26 2009 | TPIV | TAPIMMUNE INC | CORIN DENIS | President | Buy | J | 0.10 | 295,300 | 29,530 | 295,300 | 0 to 295.3 K |
Oct 26 2009 | TPIV | TAPIMMUNE INC | CORIN DENIS | President | Buy | J | 0.10 | 1,925,750 | 192,575 | 1,933,750 | 8 K to 1.9 M (+24,071.88 %) |
Oct 16 2009 | TPIV | TAPIMMUNE INC | MOORE TRACY A | Chief Financial Off ... | Grant | A | 0.97 | 500,000 | 485,000 | 500,000 | 0 to 500 K |